ATA与ETA超声风险分层系统前瞻性验证
该前瞻性研究纳入340例患者的432个甲状腺结节,验证并比较ATA与ETA超声风险分层系统对细针穿刺细胞学检查(FNAC)决策的指导价值。结果显示两系统鉴别良恶性结节能力相似,分别有23.7%和56.0%结节不符合FNAC标准,低风险类别累积恶性率分别为1.2%和1.7%。
要点
- ATA与ETA超声风险分层系统均能有效分层甲状腺结节恶性风险。
- 按ATA和ETA系统,分别有23.7%和56.0%结节不符合FNAC标准。
- 低风险类别累积恶性率ATA为1.2%,ETA为1.7%。
核心结论
- ETA与ATA超声风险分层系统能有效对甲状腺结节进行恶性风险分层。
- 采用该方法有望减少不必要的FNAC而不遗漏临床相关甲状腺癌。
研究设计与样本
- 前瞻性评估340例患者的432个选做FNAC的甲状腺结节。
- 细胞学报告基于英国甲状腺协会标准的五个类别。
主要发现
- 随着超声风险级别升高,Thy2结节比例显著下降,Thy4/Thy5结节比例显著上升(P < 0.0001)。
- ATA与ETA系统鉴别良恶性结节的能力相似。
- 按ATA和ETA系统,分别有23.7%和56.0%结节不符合FNAC标准。
- 仅考虑较低恶性风险类别时,累积恶性率ATA为1.2%,ETA为1.7%。
关键数值与推荐
- ATA系统:23.7%结节不符合FNAC标准,低风险类别累积恶性率1.2%。
- ETA系统:56.0%结节不符合FNAC标准,低风险类别累积恶性率1.7%。
临床怎么用
- 原文结论认为采用超声风险分层方法有望减少不必要的FNAC而不遗漏临床相关甲状腺癌。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Recently, the American Thyroid Association (ATA) and the European Thyroid Association (ETA) have proposed that thyroid ultrasound (US) should be used to stratify the risk of malignancy in thyroid nodules and to aid decision-making about whether fine-needle aspiration cytology (FNAC) is indicated. OBJECTIVE: To validate and to compare the ATA and ETA US risk stratification systems of thyroid nodules in a prospective series of thyroid nodules submitted to FNAC. SETTING: We prospectively evaluated 432 thyroid nodules selected for FNAC from 340 patients. Cytology reports were based on the five categories according to the criteria of the British Thyroid Association. RESULTS: The proportion of Thy2 nodules decreased significantly, whereas the proportion of Thy4/Thy5 nodules significantly increased with increasing US risk class (P < 0.0001). The ability to identify benign and malignant nodules was similar between ATA and ETA systems. According to ATA and ETA US risk stratification systems, 23.7% and 56.0% nodules did not meet the criteria for FNAC, respectively. Considering only categories at lower risk of malignancy, the cumulative malignancy rate in these nodules was 1.2% for ATA and 1.7% for ETA US risk stratification systems. CONCLUSIONS: ETA and ATA US risk stratification systems provide effective malignancy risk stratification for thyroid nodules. In clinical practice, using this approach, we should be able to reduce the number of unnecessary FNAC without losing clinically relevant thyroid cancer.
引用
- Maino F, Forleo R, Martinelli M, et al. Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC. J Clin Endocrinol Metab. 2018. PMID: 29672763. doi:10.1210/jc.2018-00274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。